Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons

Pericàs JM, Tacke F, Anstee QM, Di Prospero NA, Skalshøj Kjær M, Mesenbrink P, Koenig F, Genescà J, Ratziu V; EU-PEARL NASH Investigators. J Hepatol. 2022 Oct 7:S0168-8278(22)03131-2. doi: 10.1016/j.jhep.2022.09.021.